ReNeuron To Pay Neuralstem To End Stem Cell Row

Law360, New York (January 28, 2011, 3:10 PM EST) -- Neuralstem Inc. said Friday that British stem cell company ReNeuron Ltd. would pay it an undisclosed amount to end a trade secrets and contract dispute, following the Ninth Circuit's rejection of ReNeuron's bid to send the dispute to England.

A stipulation of dismissal was filed Thursday in the U.S. District Court for the Central District of California. U.S.-based Neuralstem said ReNeuron had agreed to immediately compensate its rival, as well as make future payments based on the successful development of certain stem cell products.

Additional financial...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.